Clinical Trial Update: Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions [NA]

View source ↗

Summary

The trial evaluating safety and effectiveness of Sepraspray for reducing post-surgical abdominal adhesions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Adhesions

Drugs mentioned

• Sepraspray

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Abdominal Adhesions | NA | Status: TERMINATED